Home
>
US Stocks
>
Avadel Pharmaceuticals plc - ADR
Avadel Pharmaceuticals plc - ADR
AVDL

Avadel Pharmaceuticals plc - ADR (AVDL)

$8.163.43%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
7.92
Today Low/High
7.77 / 8.2
52 Week Low/High
$4.95 / $10.8
Market Cap
$495.72M

Company Details

Avadel Pharmaceuticals plc is a biopharmaceutical company primarily focused on the development and FDA approval of FT218, an investigational, once-nightly, extended-release formulation of sodium oxybate designed to treat excessive daytime sleepiness and cataplexy in adults with narcolepsy.
Organisation
Avadel Pharmaceuticals plc - ADR
Headquaters
Dublin, Dublin, Ireland
Employees
2.02K
Industry
Health Technology
CEO
Gregory Divis

Discover more

Frequently Asked Questions

What is Avadel Pharmaceuticals plc - ADR (AVDL) share price today?

Can Indians buy Avadel Pharmaceuticals plc - ADR (AVDL) shares?

How can I buy Avadel Pharmaceuticals plc - ADR (AVDL) shares from India?

Can Fractional shares of Avadel Pharmaceuticals plc - ADR (AVDL) be purchased?

What are the documents required to start investing in Avadel Pharmaceuticals plc - ADR (AVDL) stocks?

We are a SEBI registered investement advisor